323 related articles for article (PubMed ID: 7094420)
1. Monocyte function in Hodgkin's disease.
Holm G; Björkholm M; Johansson B; Mellstedt H; Lindemalm C
Clin Exp Immunol; 1982 Jan; 47(1):162-8. PubMed ID: 7094420
[TBL] [Abstract][Full Text] [Related]
2. Suppression of monocyte dependent lymphocyte stimulation by sera from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Nilsson P
J Clin Lab Immunol; 1982 Jan; 7(1):51-4. PubMed ID: 6461767
[TBL] [Abstract][Full Text] [Related]
3. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
4. [Monocyte cytotoxicity in Hodgkin's disease].
Pehamberger H; Ludwig H; Pötzi P; Pietschmann H; Knapp W
Acta Med Austriaca; 1979; 6(5):249-51. PubMed ID: 555222
[TBL] [Abstract][Full Text] [Related]
5. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
7. Activation of human peripheral blood lymphocytes by concanavalin A dependence of monocytes.
Hedfors E; Holm G; Pettersson D
Clin Exp Immunol; 1975 Nov; 22(2):223-9. PubMed ID: 1082399
[TBL] [Abstract][Full Text] [Related]
8. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
Fisher RI
Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous lymphocyte proliferation and depressed cellular immunity in Hodgkin's disease.
Shiftan TA; Caviles AP; Mendelsohn J
Clin Exp Immunol; 1978 Apr; 32(1):144-52. PubMed ID: 668190
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of monocyte-mediated, antibody-dependent cytotoxicity in mycosis fungoides.
Kragballe K; Herlin T; Ellegaard J
Arch Dermatol; 1983 Mar; 119(3):203-6. PubMed ID: 6824357
[TBL] [Abstract][Full Text] [Related]
11. Increased number of functionally defective large granular lymphocytes in lymphoma patients.
Muhonen T; Teerenhovi L; Saksela E
Nat Immun Cell Growth Regul; 1987; 6(2):57-64. PubMed ID: 3600676
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of lymphocytes from patients with Hodgkin's disease.
Holm G; Björkholm M; Mellstedt H; Johansson B
Clin Exp Immunol; 1975 Sep; 21(3):376-83. PubMed ID: 1081933
[TBL] [Abstract][Full Text] [Related]
13. Polymorphonuclear leukocyte, monocyte, and macrophage bactericidal function in patients with Hodgkin's disease.
Steigbigel RT; Lambert LH; Remington JS
J Lab Clin Med; 1976 Jul; 88(1):54-62. PubMed ID: 819604
[TBL] [Abstract][Full Text] [Related]
14. Neoplastic cells obtained from Hodgkin's disease function as accessory cells for mitogen-induced human T cell proliferative responses.
Fisher RI; Bates SE; Bostick-Bruton F; Tuteja N; Diehl V
J Immunol; 1984 May; 132(5):2672-7. PubMed ID: 6609204
[TBL] [Abstract][Full Text] [Related]
15. [Antibody response in cultures of lymphocytes from patients with Hodgkin's lymphoma: role of monocytes].
Villa ML; Colleoni M; Valenti F; Tondini C; Clerici E
Boll Ist Sieroter Milan; 1987; 66(3):214-21. PubMed ID: 3325076
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's disease. An immunodepleting and immunosuppressive disorder.
Twomey JJ; Laughter AH; Farrow S; Douglass CC
J Clin Invest; 1975 Aug; 56(2):467-75. PubMed ID: 125290
[TBL] [Abstract][Full Text] [Related]
17. [Phagocytosis measurement in Hodgkin's disease and Non-Hodgkin lymphoma-patients with a new radiometric assay (author's transl)].
Süss J; Balázs C; Bakács T
Allerg Immunol (Leipz); 1982; 28(1):56-63. PubMed ID: 6214175
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
19. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
20. Effect of BM 12 531 on in vitro induction of suppressor cells by concanavalin A in cancer patients and normal healthy donors.
Somasundaram R; Advani SH; Shetye MR; Gangal SG
J Clin Lab Immunol; 1986 Jan; 19(1):43-7. PubMed ID: 2939248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
